These two rarely get their own threads so I am bundling them, with links to both Library pages. Different mechanisms, but both suffer from the same problem: interesting biology, very little human data.
MOTS-c is a mitochondrial-derived peptide with genuinely fascinating basic-science work around metabolic regulation and exercise mimetic effects, mostly in rodents. DSIP (delta sleep-inducing peptide) has been studied since the 70s in the context of sleep but the human findings are old, inconsistent, and honestly kind of murky about whether it reliably does anything.
For anyone who has read deeper than I have: is there any recent human work on either that moves the needle, or are we still firmly in 'promising mechanism, no clinical answer' territory?